Pathologic Assessment of Invasion in TUR Specimens. A. Lopez-Beltran. T1 (ct1)

Similar documents

The Depth of Tumor Invasion is Superior to 8 th AJCC/UICC Staging System to Predict Patients Outcome in Radical Cystectomy.

Jesse K. McKenney, MD

BLADDER CANCER EPIDEMIOLOGY

TOPICS FOR DISCUSSION

Carcinoma of the Urinary Bladder Histopathology

GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER

Urinary Bladder, Ureter, and Renal Pelvis

The pathology of bladder cancer

6/5/2010. Renal vein invasion & Capsule Penetration (T3a) Adrenal Gland involvement (T4 vs. M1) Beyond Gerota s Fascia? (?T4).

Staging and Grading Last Updated Friday, 14 November 2008

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

Update on bladder neoplasia: 2016 WHO classification and recent developments within the pathologic, molecular & clinical domains of the disease

A215- Urinary bladder cancer tissues

Staging and reporting of urothelial carcinoma of the urinary bladder

ACCME/Disclosures. Case History 4/13/2016. USCAP GU Specialty Conference Case 3. Ann Arbor, MI

Carcinoma of the Renal Pelvis and Ureter Histopathology

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

Bladder Case 1 SURGICAL PATHOLOGY REPORT. Procedure: Cystoscopy, transurethral resection of bladder tumor (TURBT)

A patient with recurrent bladder cancer presents with the following history:

Q&A. Fabulous Prizes. Collecting Cancer Data: Bladder, Renal Pelvis, and Ureter 5/2/13. NAACCR Webinar Series

Joseph H. Williams, MD Idaho Urologic Institute St. Alphonsus Regional Medical Center September 22, 2016

Urinary Bladder, Ureter, and Renal Pelvis

Prostate cancer staging and datasets: The Nitty-Gritty. What determines our pathological reports? 06/07/2018. Dan Berney Maastricht 2018

Urinary Bladder: WHO Classification and AJCC Staging Update 2017

Immunohistochemistry and Bladder Tumours

Controversies in the management of Non-muscle invasive bladder cancer

Uterine Cervix. Protocol applies to all invasive carcinomas of the cervix.

5/21/2018. Prostate Adenocarcinoma vs. Urothelial Carcinoma. Common Differential Diagnoses in Urological Pathology. Jonathan I.

Pathology of bladder cancer in Egypt; a current study.

Can MRI Improve Triage of Bladder Cancer Patients. John Chang, M.D., Ph.D. Banner MD Anderson Cancer Center

How Many Diseases in Carcinoma in situ?

malignant polyp Daily Challenges in Digestive Endoscopy for Endoscopists and Endoscopy Nurses BSGIE Annual Meeting 18/09/2014 Mechelen

Large blocks in prostate and bladder pathology

Staging Challenges in Lower GI Cancers. Disclosure of Relevant Financial Relationships. AJCC 8 th edition and CAP protocol updates

Collection of Recorded Radiotherapy Seminars

Mody. AIS vs. Invasive Adenocarcinoma of the Cervix

BLADDER CANCER: PATIENT INFORMATION

PATTERNS OF INVASION AND PROBLEMS IN ASSESSMENT OF INVASION BY UROTHELIAL CARCINOMA. AP110 Urinary Bladder Biopsy Interpretation: Part 2

UROTHELIAL CELL CANCER

Synonyms. Nephrogenic metaplasia Mesonephric adenoma

Update on staging colorectal carcinoma, the 8 th edition AJCC. General overview of staging. When is staging required? 11/1/2017

The Pathologist s Role in the Diagnosis and Management of Neoplasia in Barrett s Oesophagus Cian Muldoon, St. James s Hospital, Dublin

EAU GUIDELINES ON NON-MUSCLE INVASIVE (TaT1, CIS) BLADDER CANCER

Pathology Driving Decisions

Unknown Slides Conference

Reviewing Immunotherapy for Bladder Carcinoma In Situ

Earlyoesophagealcancer. dr. Nina Zidar Institute of Pathology Faculty ofmedicine University of Ljubljana Slovenia

UICC TNM 8 th Edition Errata

Disclosures. Outline. What IS tumor budding?? Tumor Budding in Colorectal Carcinoma: What, Why, and How. I have nothing to disclose

Update on Bladder Cancer: What s New in the 2016 WHO Classification of Bladder Tumors and 8 th Edition of AJCC Staging Manual

4/12/2018. MUSC Pathology Symposium Kiawah Island April 18, Jesse K. McKenney, MD

CPC on Cervical Pathology

UICC TNM 8 th Edition Errata

Q&A. Collecting Cancer Data: Bladder. Collecting Cancer Data: Bladder 3/3/2011. NAACCR Webinar Series 1. Agenda

Morphologic Criteria of Invasive Colonic Adenocarcinoma on Biopsy Specimens

Multiple Primary and Histology Site Specific Coding Rules URINARY. FLORIDA CANCER DATA SYSTEM MPH Urinary Site Specific Coding Rules

AP Slide Seminar: Tumors and Tumor-like Lesions of the Urinary Bladder. David Grignon MD, FASCP

Harry W. Herr and S. Machele Donat Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Bladder Cancer Early Detection, Diagnosis, and Staging

Pathology review impacts clinical management of patients with T1 T2 bladder cancer

Gastric Cancer Histopathology Reporting Proforma

Contemporary management of high-grade T1 bladder cancer Arnulf Stenzl

Tumours of the Oesophagus & Gastro-Oesophageal Junction Histopathology Reporting Proforma

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)

Papillary Lesions of the breast

Guidelines on Non-muscle invasive Bladder Cancer (TaT1 and CIS)

Prognostic factors of genitourinary tumors: Do we have to care?

Melanoma Update: 8th Edition of AJCC Staging System

OSCaR Update. Manager s Update. Upcoming Events. Donald Shipley, MS

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)

3/23/2017. Significant Changes in Prostate Cancer Classification, Grading, Staging and Reporting. Disclosure of Relevant Financial Relationships

Second transurethral resection against Ta high grade tumor:residual location and predictive factor. A single center, retrospective study

Radical Cystectomy Often Too Late? Yes, But...

5/26/16: CT scan of the abdomen showed a multinodular liver disease highly suspicious for metastasis and hydronephrosis of the right kidney.

Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy

Invasive Papillary Breast Carcinoma

International Society of Gynecological Pathologists Symposium 2007

Malignant tumors of melanocytes : Part 3. Deba P Sarma, MD., Omaha

Squamous Cell Carcinoma of the Head and Neck (SCCHN)


Microcystic transitional cell carcinoma: a rare tumor of the urinary bladder

Handling and Pathology Reporting of Specimens with Carcinoma of the Urinary Bladder, Ureter, and Renal Pelvis $

Patient identifiers Date of request Accession/Laboratory number. TUMOUR FOCALITY (Note 4) (Note 3)

3. Guidelines for Reporting Bladder Cancer, Prostate Cancer and Renal Tumours

Esophageal Cancer Staging Essentials: The New TNM Staging System (7th edition) and Clinicoradiologic Implications

Male genital tract tumors. SiCA. Division of Urology, Department of Surgery, Faculty of Medicine Siriraj Hospital.

GOBLET CELL CARCINOID. Hanlin L. Wang, MD, PhD University of California Los Angeles

GOBLET CELL CARCINOID

Original Article APMC-276

Immunohistochemical determinations in evaluating the prognostic in patient with urinary bladder tumors

ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology

비뇨병리연구회공청회 조남훈 연세대학교병리학교실

Haematuria and Bladder Cancer

2% of all malignancies Male predominance Patients usually more than 60 years old

Protocol for the Examination of Specimens From Patients With Carcinoma of the Urinary Bladder

The quintessential role of the surgical pathologist in

Recently, there has been an increasing incidence among women and younger persons

Transcription:

Pathologic Assessment of Invasion in TUR Specimens A. Lopez-Beltran T1 (ct1) 1

Prognostic factors for progression/invasive disease Ta,T1,CIS- NMIBC :TNM 2017 ESSENTIAL: Grade T stage CIS Number of lesions Previous recurrences ADDITIONAL Recurrence at 3 month check Tumor size>> 3 cm Prognostic factors metastasis risk/survival MIBC T2-4No-1 :TNM 2017 ESSENTIAL: T category N category ADDITIONAL Grade Histological type LVI Concomitant CIS Tumor size Hydronephrosis 2

Background T1 assessment and pitfalls T1 substaging-proposals T2 assessment and pitfalls AJCC/TNM 2017 pt1: Tumor invades subepithelial connective tissue, AJCC/TNM 2017 3

50-80% 4

T1G3 Lamina propria invasion 5

Important pathologic problem: Reproducibility in pt1 Reproducibility of lamina propria invasion (reviewed by Lopez-Beltran and Cheng, 2003 61% agreement; 10% NO consensus after 4 rounds 15% of pt1 down-staged as pta 22% of pt2 down-staged to pt1 or pta 80% agreement; 88% after a 2nd round 35% pt1 to pta; 3% to pt2-t3 2nd TURBT found: 2-28% pt1 to be at least pt2 pt1 (experts) study: (Histopathology 2013) Full agreement (44%) Majority consensus (72%) Kappa ~ 50% 6

Any Role of IHC in Invasion? 7

CK 8

T1 Substaging 9

Muscularis Mucosae and invasion Role of IHC Desmin ISUP consensus on IHC Amin, Trypkov, Lopez-Beltran et al 2014 Smoothelin 10

Caldesmon pt1 substaging is significant in patient survival? Cheng et al 2009 11

T1<0.5 mm: x400 field T1<1mm: x200 field T1<1.5 mm: x100 field 12

Recent proposals for T1 substaging Recent proposals for T1 substaging 13

Another important issue in pt1 is the level of invasion Microinvasion vs. established invasion T1mic 14

Supervivencia acum T1 Funciones de supervivencia 1,0 0,8 Anatomía_T1FvsTa T1F Ta T1F-censurado Ta-censurado 0,6 0,4 0,2 0,0 0 20 40 60 80 Tiempo_Progresión 100 120 P=.036 Lopez-Beltran et al 15

Can we improve Invasion assessment? PATHOLOGIC ISSUES IN DIAGNOSIS OF LAMINA PROPRIA MICROINVASION How we do identify invasion? HOW: General Features Histologic grade Stroma-epithelial interface (basement membrane) Invading epithelium Stromal response WHERE: Bladder Tumors with MICROINVASION CIS with microinvasion Papillary urothelial carcinoma with microinvasion Papillary urothelial carcinoma with invasion into stalk Well-established invasion into underlying lamina propria Urothelial carcinoma with endophytic/broad front growth pattern 16

HGT1 17

Lamina propria invasion Main Issues to identify Invading epithelium Irregularly shaped nests Single cell infiltration Irregular or absent basement membrane Tentacular finger-like processes Invasive component with higher nuclear grade or more cytoplasm: paradoxical differentiation Vascular invasion Lamina propria microinvasion Main Issues to identify Stromal response Desmoplasia Retraction artifact Inflammation Myxoid stroma Pseudosarcomatous stroma Absent stroma response 18

19

20

There are always difficult cases>> inform the urologist Microinvasion Examples 21

T1 bladder cancer Nests without capillary net Nests retraction T1 bladder cancer Small and big nests 22

No Microinvasion Pushing growth Big regular nests No Microinvasion Regular nests Peripheral b.m and capillary net 23

No Microinvasion 24

Broad Front Invasion INVERTED GROWTH Invasive Growth Patterns of Cancer The diagnosis of invasion should be made when there are: Irregularities of the contours of the neoplastic nests Jagged edges Desmoplastic or inflammatory stroma surrounding these nests. 25

Invasive Bladder Cancer Stage pt2 at least Stage pt2 Muscularis propria/detrusor muscle 26

T3 bladder cancer???? 53% 100% Am.J.Surg. Pathol. 2000, 24: 1286 BE CAREFUL WITH FAT TISSUE Bladder Cancer Staging AJCC/TNM 2016. Category T T0... No evidence of primary tumor Tis... Urothelial Carcinoma In Situ (Flat Tumor) Ta... Papillary tumor without invasion T1... Subepithelial connective tissue invasion (invades lamina propria) T2... Muscularis propia invasion a.- Superficial invasion (inner half) b.- Deep (outer half) T3... Perivesical fat tissue invasion a.- Microscopically b.- Macroscopically T4...Extravesical invasions a.-prostatic stroma, uterus, vagina b.-pelvic wall, abdominal wall 27

Invasive urothelial carcinoma Depth of invasion pt system of staging has an excellent correlation with prognosis 5-year survival pt1 75% pt2 40% pt3-pt4 20% Bladder Cancer: Pattern of Invasion Nodular. Kakizoe, 1980 s Biblioteca Universitaria de CórdobaBiblioteca Universitaria de Córdoba 28

Bladder Cancer: Pattern of Invasion Nodular Trabecular Biblioteca Universitaria de CórdobaBiblioteca Universitaria de Córdoba T2 bladder cancer Infiltrative MEDIAN SURVIVAL 5 Years Infiltrative pattern 29 months Non infiltrative pattern 85 months Jimenez R, Am. J. Surg. Pathol. 2000; 24: 980 29

Is this Stage T2 bladder cancer? Defining invasion of muscularis propria? Confusing terms that should be avoided: Superficial muscle invasion Deep muscle invasion Muscle invasion NOS Distinction between muscularis mucosae and muscularis propria is critical>>therapy Numerous blood vessels admixed with small bundles of smooth mucle>> MM Dense bundles of smooth muscle>> MP Biblioteca Universitaria de CórdobaBiblioteca Universitaria de Córdoba 30

Are there situations in which it is difficult to define MP? Difficult cases? Inform the urologist? In selected cases (rare)>>diagnosis of undeterminate for type of mucle>>r-resection is mandatory Do not atempt to substage MP invasion (Turb) Presence/absence of MP should be included always in the final report >>> feedback to the urologist Cauthery artefact>>difficult to differentiate in some cases MM vs. MP IHC with anti-smooth muscle actin/desmin/smoothelin/vimentin>>helpful in selected cases 31

Difficult cases? Example Biblioteca Universitaria de CórdobaBiblioteca Universitaria de Córdoba 32

2017 33

Take-Home Messages There is a need to define T1 sub-staging with criteria and methods to be applied When detrusor muscle is positive sign out as stage T2 at least When not clear if positive muscle is MM or MP talk to urologist A R-TUR will solve the problem in most cases IHC has potential value in selected cases. Follow AJCC 2017 in practice 34

THANKS! THANKS Cordoba, Spain 2008 35